Robo Global® Healthcare Technology and Innovation ETF(HTEC)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
2-STAR RATING
Consider higher Upturn Star rating
BUY for 106 days
PROFIT SINCE LAST BUY
+32.1% ▲
LAST CLOSE
$46.01
10/28/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for HTEC

10/28/2026: HTEC (2-star) has a low Upturn Star Rating. Not recommended to BUY.

HTEC provides targeted exposure to the intersection of healthcare and technology by tracking a proprietary index of global innovators. It offers a thematic approach that captures potential growth in robotics, digital health, and precision medicine, which are not fully represented in broad-market healthcare ETFs. While it provides unique exposure, investors must weigh its higher expense ratio and lower liquidity against the long-term potential of its specialized holdings. The primary risks include sector concentration, interest rate sensitivity, and inherent volatility. It is most suitable for growth-oriented investors willing to maintain a long-term time horizon for their portfolio.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe focus on disruptive healthcare technology aligns well with long-term growth objectives.
Momentum investorStrong fit while signal remains positiveInvestors can capitalize on positive sector momentum during periods of high innovation and adoption.
Value investorWeak fitThe high valuations inherent in innovative healthcare companies often conflict with traditional value-based metrics.
Dividend/Income investorWeak fitThe fund prioritizes capital appreciation over dividend income, as most holdings reinvest earnings.
Low-risk investorWeak fitThe sector's inherent volatility and concentration make it unsuitable for risk-averse portfolios.

Investor Profile

Ideal Investor Profile

The ideal investor is one seeking long-term capital appreciation and has a high tolerance for volatility, specifically wishing to gain thematic exposure to healthcare innovation.

Suitability

HTEC is best suited for long-term growth-oriented investors who can tolerate thematic sector risks, rather than active traders or passive broad-market index followers.

Risk Profile

Risk factorLevelWhy it matters
VolatilityHighThematic investments in innovation often experience sharp price swings.
Market riskMedium / highGeneral market downturns disproportionately affect high-multiple growth stocks.
ConcentrationHighThe focus on a narrow sector increases exposure to industry-specific regulatory or technological failures.
Tracking/expenseMediumHigher expense ratios compared to broad ETFs can drag on long-term performance.
LiquidityMediumLower average daily volume can lead to wider spreads and difficult entry or exit for larger positions.
Business/sector qualityMediumThe success of the fund depends on the clinical and commercial viability of the underlying companies' technologies.

Risk Analysis

Volatility

HTEC exhibits high volatility due to its concentrated exposure to innovative and often smaller-cap healthcare technology firms.

Market Risk

The fund is highly sensitive to changes in sector-specific regulation and the broader performance of growth-oriented technology stocks.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
Healthcare Equipment & SuppliesMedical Device and Robotics Manufacturers45These companies provide the foundational hardware and robotic tools used in modern precision surgery and patient care.
Health Care TechnologyDigital Health and Diagnostic Systems35This sector includes companies developing software, AI, and digital platforms that improve diagnostic accuracy and patient monitoring.
Biotechnology / Life SciencesPrecision Medicine and Genetic Innovation15Exposure to companies using advanced technology to develop personalized treatments and genomic solutions.
Cash/collateralCash and Cash Equivalents5Reflects minimal residual cash held for operational purposes or pending reinvestment.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type ETF
Historic Profit 54.97%
Avg. Invested days 72
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
ETF Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 10/28/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.